800-QUIT-NOW | Ohio Tobacco QUIT LINE. Call it Quits.

Ohio Tobacco QUIT LINE’s FREE telephone service has helped tens of thousands of Ohioans quit smoking, dipping or chewing tobacco. QUIT LINE callers are 5 times more likely to quit for good.

Why Refer QUIT LINE?

Special Topics

Medicare/Medicaid Claims

Special Help for Nurses

Pharmacotherapy

The use of pharmacotherapy approximately doubles a patient’s chance of quitting (1). As a result, the U.S. Public Health Service Clinical Practice Guideline, Treating Tobacco Use and Dependence, recommends prescribing pharmacotherapy for all patients attempting to quit, unless special circumstances warrant otherwise (e.g., pregnancy, medical contraindications, adolescent patients, patients smoking fewer than 10 cigarettes per day).

Clinicians should encourage patients to use one or a combination of approved pharmacotherapies.

Click here for an “NRT Options” chart, which includes a list of available Nicotine Replacement Therapy (NRT) medications, dosing instructions, and average costs.
Patients who enroll with Ohio Tobacco QUIT LINE may be eligible for FREE or REDUCED COST nicotine patches. Callers to OhioQuits who used nicotine patches in combination with counseling achieved a nearly 40% quit rate, compared to a 22% quit rate for those who used counseling alone.

NRT is available with passive or active dosing. The nicotine transdermal patch is the exclusive NRT product with passive dosing, producing relatively steady doses in the body. The other NRT products – nicotine gum, lozenge, inhaler, and nasal spray – have active dosing, allowing the patient to adjust dosing on an acute basis. Patients should not smoke while using nicotine replacement treatments.

(1) Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Public Health and Human Services. Public Health Service. June 2000.

Chantix
Chantix™ (varenicline) is a prescription medicine specifically developed to help adults quit smoking. According to the U.S. Food and Drug Administration (FDA), Chantix acts at sites in the brain affected by nicotine and may help those who wish to give up smoking in two ways: by providing some nicotine effects to ease the withdrawal symptoms and by blocking the effects of nicotine from cigarettes if they resume smoking.

The approved course of Chantix treatment is 12 weeks. Patients who successfully quit smoking during Chantix treatment may continue with an additional 12 weeks of Chantix treatment to further increase the likelihood of long-term smoking cessation.

Using smoking cessation medicines, such as Chantix, in conjunction with quit counseling increases the likelihood that the patient will successfully quit. OhioQuits, (1-800-QUIT-NOW) provides free individualized quit counseling for all Ohioans ready to quit tobacco.

Taking CHANTIX and other smoking cessation medicines, such as nicotine patches, at the same time has not been studied and is therefore not recommended.

For more information on Chantix, visit the FDA at www.fda.gov or Chantix at www.chantix.com.